C14ORF126 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.968040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.549400E-01
Normal-vs-Stage2
1.868980E-01
Normal-vs-Stage3
8.400500E-03
Normal-vs-Stage4
8.915000E-01
Stage1-vs-Stage2
6.539800E-01
Stage1-vs-Stage3
3.328400E-02
Stage1-vs-Stage4
5.494400E-01
Stage2-vs-Stage3
1.149560E-01
Stage2-vs-Stage4
2.221200E-01
Stage3-vs-Stage4
1.750980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.143600E-01
Normal-vs-AfricanAmerican
2.727600E-01
Normal-vs-Asian
1.158810E-01
Caucasian-vs-AfricanAmerican
9.799800E-01
Caucasian-vs-Asian
3.923800E-01
AfricanAmerican-vs-Asian
5.698200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.382410E-01
Normal-vs-Female
2.970400E-01
Male-vs-Female
2.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.646200E-01
Normal-vs-Age(41-60Yrs)
2.601000E-01
Normal-vs-Age(61-80Yrs)
1.901360E-01
Normal-vs-Age(81-100Yrs)
9.321700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.619600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.868000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.679000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.098300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.951000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.812400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.425210E-01
Normal-vs-Daily Drinker
7.588200E-02
Normal-vs-Weekly Drinker
4.077200E-01
Normal-vs-Occasional Drinker
3.833000E-01
Normal-vs-Social Drinker
5.078800E-01
Non Drinker-vs-Daily Drinker
6.410200E-01
Non Drinker-vs-Weekly Drinker
7.230800E-01
Non Drinker-vs-Occasional Drinker
1.897830E-01
Non Drinker-vs-Social Drinker
2.549800E-01
Daily Drinker-vs-Weekly Drinker
5.565600E-01
Daily Drinker-vs-Occasional Drinker
8.597800E-02
Daily Drinker-vs-Social Drinker
1.446210E-01
Weekly Drinker-vs-Occasional Drinker
5.588800E-01
Weekly Drinker-vs-Social Drinker
6.099400E-01
Occasional Drinker-vs-Social Drinker
9.869800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.093600E-01
Normal-vs-Grade 2
6.656800E-01
Normal-vs-Grade 3
2.538000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.142800E-01
Grade 1-vs-Grade 3
5.050600E-01
Grade 1-vs-Grade 4
3.093600E-01
Grade 2-vs-Grade 3
5.863800E-01
Grade 2-vs-Grade 4
6.656800E-01
Grade 3-vs-Grade 4
2.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.607600E-01
Normal-vs-NonDiabetic
1.740640E-01
Diabetic-vs-NonDiabetic
7.260800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.995700E-03
Normal-vs-NoPancreatitis
2.262600E-01
Pancreatitis-vs-NoPancreatitis
2.315500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.577230E-01
Normal-vs-N1
2.264200E-01
N0-vs-N1
4.727000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.747400E-01
Normal-vs-TP53-NonMutant
3.324200E-01
TP53-Mutant-vs-TP53-NonMutant
9.586800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
